Purity Analysis and Impurities Determination by AEX-HPLC

Handbook of Analysis of Oligonucleotides and Related Products

Volumn , Issue , 2011, Pages 47-104

  Thayer, Jim ^a   Murugaiah, Veeravagu ^b   Wu, Yansheng ^c  

^a DIONEX CORPORATION   (United States)

^b ALNYLAM PHARMACEUTICALS   (United States)

^c Archemix Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79956280999     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b10714-7     Document Type: Chapter

References (110)

1. Rahman, K., U. Voss, P. J. Nicholls, and A. D. B. Malcolm. 1988. Nucleic acid purification by Fast Protein liquid chromatography. Biochemical Society Transactions 16: 368.
2. Yeung, A. T., and C. G. Miller. 1990. A general method of optimizing automated DNA synthesis to decrease chemical consumption to less than half. Analytical Biochemistry 187: 66-75.
3. Stribling, R. 1991. High-performance liquid chromatography of oligoguanylates at high pH. Journal of Chromatography 538: 474-479.
4. Bergot, B. J., and W. Egan. 1992. Separation of synthetic phosphorothioate oligodeoxynucleotides from their oxygenated (phosphodiester) defect species by strong-anion-exchange high-performance liquid chromatography. Journal of Chromatography 599: 35-42.
5. Bourque, A. J., and A. S. Cohen. 1994. Quantitative analysis of phosphorothioate oligonucleotides in biological fluids using direct injection fast anion-exchange chromatography and capillary gel electrophoresis. Journal of Chromatography B 662: 343-349.
6. Lu, T., and H. B. Gray, Jr. 1994. Combined pH gradient and anion-exchange high performance liquid chromatographic separation of oligodeoxyribonucleotides. Journal of Chromatography A 686: 339-343.
7. Thayer, J. R., R. M. McCormick, and N. Avdalovic. 1996. High resolution nucleic acid separations by high performance liquid chromatography. In Methods in Enzymol, ed. B. Karger and B. Hancock, 271, 147-174. New York: Academic Press.
8. Kanehara, H., M. Mizuguchi, and K. Makino. 1996. Isolation of oligodeoxynucleoside phosphorothioate diastereomers by the combination of DEAE ion-exchange and reversed-phase chromatography. Nucleosides and Nucleotides 15: 399-406.
9. Yang, X., R. P. Hodge, B. A. Luxon, R. Shope, and D. G. Gorenstein. 2002. Separation of synthetic oligonucleotide dithioates from monothiophosphate impurities by anion-exchange chromatography on a mono-q column. Analytical Biochemistry 306: 92-99.
10. Grant, G. P. G., A. Popova, and P. Z. Qin. 2008. Diastereomer characterizations of nitroxide-labeled nucleic acids. Biochemical and Biophysical Research Communications 371: 451-455.
11. GE Healthcare Application Note 18-1116-00, Strategies for large scale purification of synthetic oligonucleotides: http://www1.gelifesciences.com/aptrix/upp00919.nsf/Content/D14A5305E5FA4C74C1257628001CC150/$file/18111600AA.pdf, and GE Healthcare Application Note 18-1111-25, Automated pilot scale purification of synthetic phosphorothioate oligonucleotides http://www1.gelifesciences.com/aptrix/upp00919.nsf/Content/7B387A892A39BACCC1257628001CCB09/$file/18111125AC.pdf.
12. Xu, Q., K. Musier-Forsyth, R. P. Hammer, and G. Barany. 1996. Use of 1, 2, 4-dithiazolidine-3, 5-dione (DtsNH) and 3-ethoxy-1, 2, 4-dithiazoline-5-one (EDITH) for synthesis of phosphorothioate-containing oligodeoxyribonucleotides. Nucleic Acids Research 24: 1602-1607.
13. Cummins, L. L., M. Winniman, and H. J. Gaus. 1997. Phosphorothioate oligonucleotide metabolism: characterization of the “N+"-mer by CE and HPLC-ESI/MS. Bioorganic and Medicinal Chemistry Letters 7: 1225-1230.
14. Wang, X. D., and P. R. Gou. 2009. Polymerase-endonuclease amplification reaction for large-scale enzymatic production on antisense oligonucleotides. Nature Proceedings (hdl:10101/npre.2009.3711.1, posted 2 Sept. 2009).
15. Dean, N., R. McKay, L. Miraglia, et al. 1996. Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Research 56: 3499-3507.
16. Fearon, K. L., J. T. Stults, B. J. Bergot, L. M. Christensen, and A. M. Raible. 1995. Investigation of the ʼn-1' impurity in phosphorothioate oligodeoxynucleotides synthesized by the solid-phase β-cyanoethyl phosphoramidite method using stepwise sulfurization. Nucleic Acids Research 23: 2754-2761.
17. Koziolkiewicz, M., A. Owczarek, K. Domañski, M. Nowak, P. Guga, and W. J. Stec. 2001. Stereochemistry of cleavage of internucleotide bonds by Serratia marcescens endonuclease. Bioorganic and Medicinal Chemistry 9: 2403-2409.
18. Chen, S.-H., M. Qian, J. M. Brennan, and J. M. Gallo. 1997. Determination of antisense phosphorothioate oligonucleotides and catabolites in biological fluids and tissue extracts using anion-exchange high-performance liquid chromatography and capillary gel electrophoresis. Journal of Chromatography B 692: 43-51.
19. Chen, J.-K., R. G. Schultz, D. H. Lloyd, and S. Gryaznov. 1995. Synthesis of oligodeoxyribonucleotide N3′-P5′ phosphoramidates. Nucleic Acids Research 23: 2661-2668.
20. Asseline, U., M. Chassignol, J. Draus, M. Durand, and J-C. Maurizot. 2003. Synthesis and properties of oligo-2′-deoxyribonucleotides containing internucleotidic phosphoramidate linkages modified with pendant groups ending with either two amino or two hydroxyl functions. Bioorganic and Medicinal Chemistry 11: 3499-3511.
21. Morgan, M. T., M. T. Bennet, and A. C. Drohat. 2007. Excision of 5-halogenated uracils by human thymine DNA glycosylase. Journal of Biological Chemistry 282: 27578-27586.
22. Jurczyk, S. C., J. Horlacher, K. G. Devined, S. A. Benner, and T. R. Battersby. 2000. Synthesis and characterization of oligonucleotides containing 2′-deoxyxanthosine using phosphoramidite chemistry. Helvetica Chimica Acta 83: 1517-1524.
23. Wincott, F., A. DiRenzo, C. Shaffer, S. Grimm, D. Tracz, C. Workman, D. Sweedler, C. Gonzalez, S. Scaringe, and N. Usman. 1995. Synthesis, deprotection, analysis and purification of RNA and ribozymes. Nucleic Acids Research 23: 2677-2684.
24. Grünewald, C., T. Kwon, N. Piton, U. Förster, J. Wachtveitl, and J. W. Engels. 2008. RNA as scaffold for pyrene excited complexes. Bioorganics and Medicinal Chemistry 16: 19-26.
25. Matray, T. J., and S. M. Gryaznov. 1999. Synthesis and properties of RNA analogs oligoribonucleotide N3′-P5′ phosphoramidates. Nucleic Acids Research 27: 3976-3985.
26. Tsou, D., A. Hampel, A. Andrus, and R. Vinayak. 1995. Large scale synthesis of oligoribonucleotides on a high-loaded polystyrene (HLP) support. Nucleosides and Nucleotides 14: 1481-1492.
27. Vinayak, R., A. Andrus, N. D. Sinha, and A. Hampel. 1995. Assay of ribozyme-substrate cleavage by anion-exchange high-performance, liquid chromatography. Analytical Biochemistry 232: 204-209.
28. Sproat, B. S., T. Rupp, N. Menhardt, D. Keane, and B. Beijer. 1999. Fast and simple purification of chemically modified hammerhead ribozymes using a lipophilic capture tag. Nucleic Acids Research 27: 1950-1955.
29. Murray, J. B., C. M. Dunham, and W. G. Scott. 2002. A pH-dependent conformational change, rather than the chemical step, appears to be rate-limiting in the hammerhead ribozyme cleavage reaction. Journal of Molecular Biology 315: 121-130.
30. Earnshaw, D. J., B. Masquida, S. Müller, S. Th. Sigurdsson, F. Eckstein, E. Westhof, and M. J. Gait. 1997. Inter-domain cross-linking and molecular modeling of the hairpin ribozyme. Journal of Molecular Biology 274: 197-212.
31. Micura, R., W. Pils, C. Höbartner, K. Grubmayr, M-O. Ebert, and B. Jaun. 2001. Methylation of the nucleobases in RNA oligonucleotides mediates duplex-hairpin conversion. Nucleic Acids Research. 29: 3997-4005.
32. Massey, A. P., and S. Th. Sigurdsson. 2004. Chemical syntheses of inhibitory substrates of the RNA-RNA ligation reaction catalyzed by the hairpin ribozyme. Nucleic Acids Research 32: 2017-2022.
33. Prater, C. E., A. D. Saleh, M. P. Wear, and P. S. Miller. 2007. Chimeric RNAse H-competent oligonucleotides directed to the HIV-1 Rev response element. Bioorganic and Medicinal Chemistry 15: 5386-5395.
34. Cohen, C., M. Forzan, B. Sproat, R. Pantophlet, I. McGowan, D. Burton, and W. James. 2008. An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site. Virology 381: 46-54.
35. Mackman, R. L., L. Zhang, V. Prasad, et al. 2007. Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs. Bioorganic and Medicinal Chemistry 15: 5519-5528.
36. Nair, T. M., D. G. Myszka, and D. R. Davis. 2000. Surface plasmon resonance kinetic studies of the HIV TAR RNA kissing hairpin complex and its stabilization by 2-thiouridine modification. Nucleic Acids Research 28: 1935-1940.
37. M. A. Morgan, S. A. Kazakov, and S. M. Hecht. 1995. Phosphoryl migration during the chemical synthesis of RNA, Nucleic Acids Research 23: 3949-3953.
38. Thayer, J. R., S. Rao, N. Puri, C. A. Burnett, and M. Young. 2007. Identification of aberrant 2′-5′ RNA link age isomers by pellicular anion-exchange chromatography. Analytical Biochemistry 361: 132-139.
39. T. P. Prakash, B. Kraynack, B. F. Baker, E. E. Swayze, and B. Bhat. 2006. RNA interference by 2′, 5′-linked nucleic acid duplexes in mammalian cells. Bioorganic and Medicinal Chemistry Letters 16: 3238-3240.
40. Hovanessian, A. G., and J. Justesen. 2007. The human 2′-5′ oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2′-5′ instead of 3′-5′ phosphodiester bond formation. Biochemie 89: 779-788.
41. Soutschek, J., A. Akinc, B. Bramlage, et al. 2004. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173-178.
42. Pham, J. W., I. Radhakrishnan, and E. J. Sontheimer. 2004. Thermodynamic and structural characterization of 2′-nitrogen-modified RNA duplexes. Nucleic Acids Research 32: 3446-3455.
43. Frank-Kamentetsy, M., A. Grefhorst, N. N. Anderson, et al. 2008. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proceedings of the National Academy of Sciences United States of America 105, 11915-11920.
44. Chiu, Y.-L., and T. M. Rana. 2003. siRNA function in RNAi: a chemical modification analysis. RNA 9, 1034-1048.
45. Li, F., P. S. Pallan, M. A. Maier, et al. 2007. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: Insights into substrate requirements by the human RISC Ago2 enzyme. Nucleic Acids Research. 35: 6424-6438.
46. Mikat, V., and A. Heckel. 2007. Light-dependent RNA interference with nucleobase-caged siRNAs. RNA 13: 2341-2347.
47. Rhodes, A., A. Deakin, J. Spaull, B. Coomber, A. Aitken, P. Life, and S. Rees. 2000. The generation and characterization of antagonist RNA Aptamers to human oncostatin M. Journal of Biological Chemistry 275, 28555-28561.
48. Floege, J., T. Ostendorf, U. Janssen, M. Burg, H. H. Radeke, C. Vargeese, S. C. Gill, L. S. Green, and N. Janjic. 1999. Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. American Journal of Pathology 154: 169-179.
49. Gilbert, J. C., T. DeFeo-Fraulini, R. M. Hutabarat, C. J. Horvath, P. G. Merlino, H. N. Marsh, J. M. Healy, S. BouFakhreddine, T.V. Holohan, and R. G. Schaub. 2009. First-in-human evaluation of anti von Willebrand Factor therapeutic aptamer ARC1779 in healthy volunteers. Circulation 116: 2678-2686.
50. Fennewald, S. M., E. P. Scott, L. Zhang, et al. 2007. Thioaptamer decoy targeting of AP-1 proteins influences cytokine expression and the outcome of arenavirus infections. Journal of General Virology 88: 981-990.
51. Jackson-Kram, D., and T. McGovern. 2007. Toxicological overview of impurities in pharmaceutical products. Advanced Drug Delivery Reviews, 59: 38-42.
52. McGovern, T., and D. Jackson-Kram. 2006. Regulation of genotoxic and carcinogenic impurities in drug substances and products. Trends in Analytical Chemistry 25: 790-795.
53. U.S. DeparTment of Health and Human Services, FDA (CDER). 2006. Guidance for Industry, Investigators and Reviewers: Exploratory IND Studies, Pharmacology and Toxicology. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM078933.pdf.
54. Puffer, B., H. Moroder, M. Aigner, and R. Micura. 2008. 2′-Methylseleno-modified oligoribonucleotides for X-ray crystallography synthesized by the ACE RNA solid-phase approach. Nucleic Acids Research 36: 970-983.
55. Murray, J. B., H. Szöke, A. Szöke, and W. G. Scott. 2000. Capture and visualization of a catalytic RNA enzyme-product complex using crystal lattice trapping and X-ray holographic reconstruction. Molecular Cell 5: 279-287.
56. Pallan, P. S., C. H. Wilds, Z. Wawrzak, R. Krishnamurthy, A. Eschenmoser, and M. Egli. 2003. Why does TNA cross-pair more strongly with RNA than with DNA? An answer from X-ray analysis. Angewandte Chemie (International Edition in English) 42: 5893-5895.
57. Yang, H., and S. L. Lam. 2009. Effect of 1-methyladenine on the thermodynamic stabilities of double-helical DNA structures. FEBS Letters 583: 1548-1553.
58. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed., Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
59. Fearon, K. L., B. L. Hirschbein, J. S. Nelson, et al. 1998. An improved synthesis of oligodeoxynucleotide N3′-P5′ phosphoramidates and their chimera using hindered phosphoramidite monomers and a novel handle for reverse phase purification. Nucleic Acids Research 26: 3813-3824.
60. Tucker, C. E., L.-S. Chen, M. B. Judkins, J. A. Farmer, S. C. Gill, and D. W. Drolet. 1999. Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys. Journal of Chromatography B 732: 203-212. Also Bouchard, P. R., R. M. Hutabarat, and K. M. Thompson. 2010. Discovery and development of therapeutic aptamers. Annual Review of Pharmacology and Toxicology 50: 237-257.
61. Van Aerschot, A., and J. Rozenski. 2006. Characterization and sequence verification of thiolated deoxyoligonucleotides used for microarray construction. Journal of the American Society for Mass Spectrometry 17: 1396-1400.
62. Jiang, Y., and S. A. Hofstadler. 2003. A highly efficient and automated method of purifying and desalting PCR products for analysis by electrospray ionization mass spectrometry. Analytical Biochemistry 316: 50-57.
63. Urlaub, H., K. HarTmuth, S. Kostka, G. Grelle, and R. Lührmann. 2000. A general approach for identification of RNA-protein cross-linking sites within native human spliceosomal small nuclear ribonucleoproteins (snRNPs). Journal of Biological Chemistry 52: 41458-41468.
64. Lee, B. M., J. Xu, B. K. Clarkson, M. A. Martinez-Yamout, H. J. Dyson, D. A. Case, J. M. Gottesfeld, and P. E. Wright. 2006. Induced fit and “lock and key” recognition of 5S RNA by zinc fingers of transcription factor IIIA. Journal of Molecular Biology 357: 275-291.
65. Eon-Duval, A., and G. Burke. 2004. Purification of pharmaceutical-grade plasmid DNA by anion-exchange chromatography in and RNAse-free process. Journal of Chromatography B 804: 327-335.
66. Crary, S. M., J. C. Kurz, and C. A. Fierke. 2002. Specific phosphorothioate substitutions probe the active site of Bacillus subtilis Ribonuclease P. RNA 8: 933-947.
67. Nauwelaerts, K., K.VasTmans, M. Froeyen, et al. 2003. Cleavage of DNA without loss of genetic information by incorporation on a disaccharide nucleoside. Nucleic Acids Research 31: 6758-6769.
68. Yamaguchi, T., K. Suyama, K. Narita, S. Kohgo, A. Tomikawa, and M. Saneyoshi. 1997. Synthesis and evaluation of oligodeoxyribonucleotides containing an aryl(trifluoromethyl) diazirine moiety as the cross-linking probe: Photoaffinity labeling of mammalian DNA polymerase β. Nucleic Acids Research 25: 2352-2358.
69. Harsch, A., L. A. Marzill, R. C. Bunt, J. Stubbe, and P. Vouros. 2000. Accurate and rapid modeling of iron-bleomycin-induced DNA damage using tethered duplex oligonucleotides and electrospray ionization ion trap mass spectrometric analysis. Nucleic Acids Research 28: 1978-1995.
70. Biczo, R., and D. J. Hirsh. 2009. Structure and dynamics of a DNA-based model system for the study of electron spin-spin interactions. Journal of Inorganic Biochemistry 103: 362-372.
71. Johansson, M. K., R. M. Cook, J. Xu, and K. N. Raymond. 2004. Time gating improves sensitivity in energy transfer assays with terbium chelate/dark quencher oligonucleotide probes. Journal of the American Chemical Society 126: 16451-16455.
72. Ouyang, X., I. A. Shestopalov, S. Sinha, G. Zheng, C. L. W. Pitt, W-H. Li, A. J. Olson, and J. K. Chen. 2009. Versatile synthesis and rational design of caged morpholinos. Journal of the American Chemical Society 131: 13255-13269.
73. Semenyuk, A., M. Ahnfelt, C. EsTmer, X. Yong-Hao, A. Földesi, Y.-S. Kao, H.-H. Chen, W.-C. Kao, K. Peck, and M. Kwiatkowski. 2006. Cartridge-based high-throughput purification of oligonucleotides for reliable oligonucleotide arrays. Analytical Biochemistry 356: 132-141.
74. Junker, H-D., S. T. Hoehn, R. C. Bunt, V. Marathius, J. Chen, C. J. Turner, and J. Stubbe. 2002. Synthesis, characterization and solution structure of tethered oligonucleotides containing an internal 3′-phosphoglycolate, 5′-phosphate gapped lesion. Nucleic Acids Research 30: 5497-5508.
75. Gill, S., R. O’Neill, R. J. Lewis, and B. A. Connolly. 2007. Interaction of the Family-B DNA polymerase from the archaeon Pyrococcus furiosus with deaminated bases. Journal of Molecular Biology 372: 855-863.
76. Ye, Y., B. H. Munk, J. G. Muller, A. Cogbill, C. J. Burrows, and B. Schlegel. 2009. Mechanistic aspects of the formation of guanidinohydantoin from spiroiminodihydantoin under acidic conditions. Chemical Research Toxicology 22: 526-535.
77. Misiaszek, R., Y. Uvaydov, C. Crean, N. E. Geacintov, and V. Shafirovich. 2005. Combination reactions of superoxide with 8-oxo-7, 8-dihydroguanine radicals in DNA. Journal of Biological Chemistry 280: 6293-6300.
78. Boojamra, C. G., J. P. Parrish, D. Sperandio, et al. 2009. Design synthesis and anti-HIC activity of 4′-modified carbocyclic nucleoside phosphonate reverse transcriptase inhibitors. Bioorganic and Medicinal Chemistry 17: 1739-1746.
79. Conn, G. L., T. Brown, and G. A. Leonard. 1999. The crystal structure of the RNA/DNA hybrid rGAAGAGAAGC.d(GCTTCTCTTC) shows significant differences to that found in solution. Nucleic Acids Research 27: 555-561.
80. Nordin, B. E., and P. Schimmel. 2002. Plasticity of recognition of the 3′-end of mischarged tRNA by class-I aminoacyl-tRNA synthetases. Journal of Biological Chemistry 277: 20510-20517.
81. Fonvielle, M., M. Chemama, R. Villet, M. Lecerf, A. Bouhss, J-M. Valéry, M. Ethève-Quelquejeu, and M. Arthur. 2009. Aminoacyl-tRNA recognition by the FemXWv transferase for bacterial cell wall synthesis. Nucleic Acids Research 37: 1589-1601.
82. Garcia-Garcia, C., and D. E. Draper. 2003. Electrostatic interactions in a peptide-RNA complex. Journal of Molecular Biology 331: 75-88.
83. Perry, K., Y. Hwang, F. D. Bushman, and G. D. Van Duyne. 2006. Structural basis for specificity in the Poxvirus topoisomerase. Molecular Cell 213: 343-354.
84. Lochmann, D., J. Weyermann, C. Georgens, R. Prassl, and A. Zimmer. 2005. Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: Physicochemical characterization. European Journal of Pharmaceuticals and Biopharmaceuticals 59: 419-429.
85. Allen T. D., K. L. Wick, and K. S. Matthews. 1991. Identification of amino acids in lac repressor protein cross-linked to operator DNA specifically substituted with bromodeoxyuridine. Journal of Biological Chemistry 266: 6113-6119.
86. Matthew-Fenn, R. S., R. Das, J. A. Silverman, P. A. Walker, and P. A. B. Harbury. 2008. A molecular ruler for measuring quantitative distance distributions. PLoS ONE 3(10): e3229. doi:10.1371/journal.pone.0003229.
87. Svec, F., and J. M. J. Frechet. 1992. Continuous rods of macroporous polymer as high-performance liquid chromatography separation media. Analytical Chemistry 64: 820-822.
88. Peters, E. C., M. Petro, F. Svec, and J. M. J. Frechet. 1998. Molded rigid polymer monoliths as separation media for capillary electrochromatography. 2. Effect of chromatographic conditions on the separation. Analytical Chemistry 70: 2296-2302.
89. Svec, F., and C. G. Huber. 2006. Monolithic materials: promises, challenges, achievements. Analytical Chemistry 78: 2100-2107.
90. Perica, M. C., I. Sola, L. Urbas, F. Smrekar, and M. Krajacic. 2009. Separation of hypoviral double-stranded RNA on monolithic chromatographic supports. Journal of Chromatography A 1216: 2712-2716.
91. Thayer, J. R., K. J. Flook, A. Woodruff, S. Rao, and C. A. Pohl. 2010. New monolith technology for automated anion-exchange purification of nucleic acids. Journal of Chromatography B, 878: 933-941, doi:10.1016/j.jchromb.2010.01.030.
92. Hatefi, Y., and W. G. Hanstein. 1969. Solubilization of particulate proteins and nonelectrolytes by chaotropic agents. Proceedings of the National Academy of Sciences of the United States of America 62:1129-1136.
93. Thayer, J. R., V. Barreto, S. Rao, and C. Pohl. 2005. Control of oligonucleotide retention on a pH-stabilized strong anion exchange column. Analytical Biochemistry 338: 39-47.
94. Murakami, A., Y. Tamura, H. Wada, and K. Makino. 1994. Separation and characterization of diastereoisomers of antisense oligodeoxyribonucleoside phosphorothioates. Analytical Biochemistry 223: 285-290.
95. Patil, S. V., B. Mane, and M. M. Salunkhe. 1994. Synthesis and properties of oligothymidylate analogs containing stereoregulated phosphorothioate and phosphodiester linkages in an alternating manner. Bioorganic and Medicinal Chemistry Letters 4: 2663-2666.
96. Iyer, R. P., M.-J. Guo, D. Yu, and S. Agrawal. 1998. Solid phase stereoselective synthesis of oligonucleoside phosphorothioates: The nucleoside bicyclic oxazaphospholidines as novel synthons. Tetrahedron Letters 39: 2491-2494.
97. J. R. Thayer, Y. Wu, E. Hansen, M. D. Angelino, and S. Rao. 2010. Separation of oligonucleotide phosphorothioate diastereoisomers by anion-exchange chromatography. Analytical Chemistry. In preparation.
98. Li, H., P. S. Miller, and M. M. Seidman. 2008. Selectivity and affinity of DNA triplex forming oligonucleotides containing the nucleoside analogues 2′-O-methyl-5-(3-amino-1-propynyl)uridine and 2′-O-methyl-5-propynyluridine. Organic and Biomolecular Chemistry 6: 4212-4217.
99. Yang, C. J., L. Wang, Y. Wu, Y. Kim, C. D. Medley, H. Lin, and W. Tan. 2007. Synthesis and investigation of deoxyribonucleic acid/locked nucleic acid chimeric molecular beacons. Nucleic Acids Research 35: 4030-4041.
100. Kim, H.-J., N. A. Leal, and S. A. Benner. 2009. 2′-Deoxy-1-methylpseudocytidine, a stable analog of 2′-deoxy-5-methylisocytidine. Bioorganic and Medicinal Chemistry 17: 3728-3732.
101. Baba, Y., M. Fukuda, and N. Yoza. 1988. Computer-assisted retention prediction system for oligonucleotides in gradient anion-exchange chromatography. Journal of Chromatography 458: 385-394.
102. Alvarez, R., S. Elbashir, T. Borland, et al. 2009. RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy. Antimicrobial Agents and Chemotherapy 53: 3952-3962.
103. De Fougerolles, A., and T. Novobrantseva. 2008. siRNA and the lung: research tool or therapeutic drug. Current Opinion in Pharmacology 8: 280-285.
104. Akinc, A., M. Goldberg, J. Qin, et al. 2009. Development of lipidoid-siRNA formulations for systemic delivery to the liver. Molecular Therapy 17: 872-879.
105. Nguyen, T., E. M. Menocal, J. Harborth, and J. H. Fruehauf. 2008. RNAi therapeutics: an update on delivery. Current Opinions in Molecular Therapeutics 10: 158-167.
106. Siegel, R. W., L. Bellon, L. Beigelman, and C. C. Kao. 1998. Moieties in an RNA promoter specifically recognized by a viral RNA-dependent RNA polymerase. Proceedings of the National Academy of Sciences of the United States of America 95: 11613-11618.
107. Hail, M., B. Elliot, and K. Anderson. 2004. High-throughput analysis of oligonucleotides using automated electrospray ionization mass spectrometry. American Biotechnology Laboratory 22:12-14.
108. Thayer, J. R., N. Puri, C. Burnett, M. E. Hail, and S. Rao. 2010. Identification of RNA linkage isomers by anion-exchange purification with ESI-MS of automatically desalted phosphodiesterase-II digests. Analytical Biochemistry 399: 110-117.
109. Schleich, T., B. P. Cross, and I. C. P. Smith. 1976. A conformational study of adenylyl-(3′, 5′)-adenosine and adenylyl-(2′, 5′)-adenosine in aqueous solution by carbon-13 magnetic resonance spectroscopy. Nucleic Acids Research 3: 355-370.
110. Thayer, J. R., S. Rao, and N. Puri. 2008. Detection of aberrant 2′-5′ linkages in RNA by anion exchange. In Current Protocols in Nucleic Acid Chemistry, ed. S. Beaucage, 10.13.1-11. New York: Wiley Interscience.